Min Li, Changmin Mao, Wenjuan Li, Wenjie Xia, Kejin Li, Rong Xu
{"title":"Downregulated circ_0001681 Predicts the Occurrence and Malignant Development of Lung Carcinoma via Negatively Modulating miR-567.","authors":"Min Li, Changmin Mao, Wenjuan Li, Wenjie Xia, Kejin Li, Rong Xu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The screening and monitoring of lung adenocarcinoma (LUAD) is critical for its therapeutic efficiency. This study explored a novel biomarker of LUAD from the GSE146689 dataset and evaluated its function aiming to provide a potential therapeutic target for LUAD.</p><p><strong>Methods: </strong>There were 126 LUAD patients, 75 benign lung disease patients, and 57 healthy individuals enrolled in this study. circ_0001681 levels were evaluated by PCR, and its significance in the diagnosis and prognosis of LUAD was assessed by ROC and Cox regression analysis. The effect of circ_0001681 on LUAD cells was investigated by CCK8 and transwell assays.</p><p><strong>Results: </strong>Reduced circ_0001681 was observed in LUAD patients relative to benign lung disease patients and healthy individuals, which could discriminate LUAD patients. circ_0001681 downregulation was closely associated with the severity and malignancy of LUAD patients, and it also indicated the adverse prognosis of LUAD. In mechanism, circ_0001681 could negatively regulate miR-567, which was found to mediate the inhibitory effect of circ_0001681 on LUAD cell proliferation and motility.</p><p><strong>Conclusion: </strong>Decreased circ_0001681 in LUAD served as a biomarker in tumor occurrence and development, which can be included in the formulation and adjustment of LUAD therapeutic strategy.</p>","PeriodicalId":8228,"journal":{"name":"Annals of clinical and laboratory science","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of clinical and laboratory science","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The screening and monitoring of lung adenocarcinoma (LUAD) is critical for its therapeutic efficiency. This study explored a novel biomarker of LUAD from the GSE146689 dataset and evaluated its function aiming to provide a potential therapeutic target for LUAD.
Methods: There were 126 LUAD patients, 75 benign lung disease patients, and 57 healthy individuals enrolled in this study. circ_0001681 levels were evaluated by PCR, and its significance in the diagnosis and prognosis of LUAD was assessed by ROC and Cox regression analysis. The effect of circ_0001681 on LUAD cells was investigated by CCK8 and transwell assays.
Results: Reduced circ_0001681 was observed in LUAD patients relative to benign lung disease patients and healthy individuals, which could discriminate LUAD patients. circ_0001681 downregulation was closely associated with the severity and malignancy of LUAD patients, and it also indicated the adverse prognosis of LUAD. In mechanism, circ_0001681 could negatively regulate miR-567, which was found to mediate the inhibitory effect of circ_0001681 on LUAD cell proliferation and motility.
Conclusion: Decreased circ_0001681 in LUAD served as a biomarker in tumor occurrence and development, which can be included in the formulation and adjustment of LUAD therapeutic strategy.
期刊介绍:
The Annals of Clinical & Laboratory Science
welcomes manuscripts that report research in clinical
science, including pathology, clinical chemistry,
biotechnology, molecular biology, cytogenetics,
microbiology, immunology, hematology, transfusion
medicine, organ and tissue transplantation, therapeutics, toxicology, and clinical informatics.